Both Moderna and Pfizer will file for FDA authorization as next step

CNBC's senior health and science correspondent Meg Tirrell says it's very meaningful to have two Covid-19 vaccines, one from Pfizer and another one from Moderna that have well over 90 percent efficacy rates. She joins Shep Smith to discuss the next steps in accelerating these vaccines to the market.
Mon, Nov 16 20207:12 PM EST